Sage Therapeutics (SAGE) PT Raised to $68 at BofA Securities
Tweet
Share
E-mailGet Alerts SAGE Hot Sheet
Price: $14.06 +8.57%
Rating Summary:
7 Buy, 21 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 12 | Down: 9 | New: 14
Rating Summary:
7 Buy, 21 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 12 | Down: 9 | New: 14
Join SI Premium – FREE
BofA Securities analyst Tazeen Ahmad raised the price target on Sage Therapeutics (NASDAQ: SAGE) to $68.00 (from $66.00) while maintaining a Buy rating.
You May Also Be Interested In
- GE Aerospace (GE) PT Raised to $180 at BofA Securities
- Sage Therapeutics (SAGE) PT Lowered to $19 at Scotiabank
- Forsee Power SACA (FORSE:FP) PT Lowered to EUR1.90 at Kepler Cheuvreux
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
